Peptidream, Inc. (4587)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Peptidream, Inc. (4587)
Go deeper and ask any question about 4587
Company Performance
Current Price
as of Sep 17, 2024$17.07
P/E Ratio
14.34
Market Cap
$2.2B
Description
PeptiDream, Inc. engages in the biopharmaceutical business that includes research and development of non-standard peptide therapeutics. It operates through Drug Discovery and Development Business segment. The Drug Discovery and Development Business segment provides macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS) and engages in collaborative drug discovery research and development, technology licensing of PDPS, and expansion of pipeline through strategic alliances. The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan.
Metrics
Overview
- HQKawasaki, KN
- SectorHealth Technology
- IndustryBiotechnology
- Ticker4587
- Price$17.071039-2.65%
Trading Information
- Market Cap$2.20B
- Float73.77%
- Average Daily Volume (1m)863,110
- Average Daily Volume (3m)1,015,481
- EPS$167.35
Company
- Revenue$55.42B
- Rev Growth (1yr)615.02%
- Net Income$18.77B
- Gross Margin89.26%
- EBITDA Margin82.42%
- EBITDA$26.30B
- EV$318.77B
- EV/Revenue5.75
- P/E14.34
- P/S5.62